(Q34981769)

5 August 2017

1 reference

title

Mirtazapine: a review of its use in major depression and other psychiatric disorders (English)

1 reference

5 August 2017

2

Caroline M Perry

1 reference

5 August 2017

3

Greg L Plosker

1 reference

5 August 2017

Katherine F Croom

1

1 reference

5 August 2017

publication date

1 January 2009

1 reference

5 August 2017

1 reference

5 August 2017

volume

23

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

427-452

1 reference

A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923050-00006

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923050-00006

Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200923050-00006

Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.

21 January 2018

1 reference

12 December 2020

Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects

1 reference

12 December 2020

Population pharmacokinetic analysis of mirtazapine

1 reference

12 December 2020

Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.

1 reference

12 December 2020

A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients

1 reference

12 December 2020

Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder

1 reference

12 December 2020

Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770).

1 reference

12 December 2020

In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes

1 reference

12 December 2020

Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects

1 reference

12 December 2020

A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients

1 reference

12 December 2020

The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period

1 reference

12 December 2020

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

1 reference

12 December 2020

Antidepressants and driving ability: results from a clinical study

1 reference

12 December 2020

The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study

1 reference

12 December 2020

Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine

1 reference

12 December 2020

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder

1 reference

12 December 2020

Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial

1 reference

12 December 2020

Clinical pharmacokinetics of mirtazapine

1 reference

12 December 2020

Mirtazapine compared with paroxetine in major depression

1 reference

12 December 2020

Mirtazapine versus fluoxetine in the treatment of panic disorder

1 reference

12 December 2020

Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects.

1 reference

12 December 2020

The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England

1 reference

12 December 2020

Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study

1 reference

12 December 2020

Safety of mirtazapine: a review

1 reference

12 December 2020

Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.

1 reference

12 December 2020

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

12 December 2020

The effects of mirtazapine on plasma lipid profiles in healthy subjects.

1 reference

12 December 2020

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

1 reference

12 December 2020

Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment

1 reference

12 December 2020

Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline

1 reference

12 December 2020

Effect of mirtazapine treatment on body composition and metabolism.

1 reference

12 December 2020

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

1 reference

12 December 2020

The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care

1 reference

12 December 2020

Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring study

1 reference

12 December 2020

Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial

1 reference

12 December 2020

The pharmacologic rationale for the clinical use of antidepressants.

1 reference

12 December 2020

Mirtazapine: a review of its use in major depression

1 reference

12 December 2020

Mirtazapine. A pharmacoeconomic review of its use in depression

1 reference

12 December 2020

Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression

1 reference

12 December 2020

A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care

1 reference

12 December 2020

A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.

1 reference

12 December 2020

Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.

1 reference

12 December 2020

Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects

1 reference

12 December 2020

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

1 reference

12 December 2020

Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients

1 reference

12 December 2020

Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4

1 reference

12 December 2020

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression

1 reference

12 December 2020

Cerebrovascular reactivity following administration of mirtazapine in healthy probands--a randomized, placebo controlled double-blind clinical study

1 reference

12 December 2020

Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder

1 reference

12 December 2020

Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission

1 reference

12 December 2020

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

1 reference

12 December 2020

A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.

1 reference

12 December 2020

Pharmacokinetics of Mirtazapine: Enantioselective Effects of the CYP2D6 Ultra Rapid Metabolizer Genotype and Correlation with Adverse Effects

1 reference

12 December 2020

A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

1 reference

12 December 2020

Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.

1 reference

12 December 2020

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features

1 reference

12 December 2020

Transfer of the antidepressant mirtazapine into breast milk

1 reference

12 December 2020

Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine

1 reference

12 December 2020

Lifetime risk of depression: restricted to a minority or waiting for most?

1 reference

12 December 2020

Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression

1 reference

12 December 2020

Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant.

1 reference

12 December 2020

Restless legs syndrome as side effect of second generation antidepressants

1 reference

12 December 2020

Prevalence and incidence studies of mood disorders: a systematic review of the literature

1 reference

12 December 2020

Does mirtazapine have a more rapid onset than SSRIs?

1 reference

12 December 2020

Neurochemical effects of the enantiomers of mirtazapine in normal rats

1 reference

12 December 2020

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes

1 reference

12 December 2020

Mirtazapine treatment and sexual functions: Results of a Hungarian, multicentre, prospective study in depressed out-patients.

1 reference

12 December 2020

Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.

1 reference

12 December 2020

Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers

1 reference

12 December 2020

Sexual functioning in depressed outpatients taking mirtazapine

1 reference

12 December 2020

Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition

1 reference

12 December 2020

Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects

1 reference

12 December 2020

Pharmacokinetics and biotransformation of mirtazapine in human volunteers

1 reference

12 December 2020

Designing a new generation of antidepressant drugs

1 reference

12 December 2020

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients

1 reference

12 December 2020

The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?

1 reference

12 December 2020

Pharmacokinetics of mirtazapine and lithium in healthy male subjects

1 reference

12 December 2020

Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.

1 reference

12 December 2020

Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

1 reference

12 December 2020

Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria

1 reference

12 December 2020

Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.

1 reference

12 December 2020

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia

1 reference

12 December 2020

Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression

1 reference

12 December 2020

Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke

1 reference

12 December 2020

Mirtazapine decreases the pain feeling in healthy participants

1 reference

12 December 2020

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study

1 reference

12 December 2020

An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients

1 reference

12 December 2020

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

1 reference

12 December 2020

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

1 reference

12 December 2020

Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.

1 reference

12 December 2020

Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK

1 reference

12 December 2020

The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects

1 reference

12 December 2020

Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial

1 reference

12 December 2020

A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression

1 reference

12 December 2020

[Treatment of depression and cost efficiency. The cost of a tablet is a poor indicator seen from a socioeconomic perspective]

1 reference

12 December 2020

Mirtazapine substitution in SSRI-induced sexual dysfunction.

1 reference

12 December 2020

Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study

1 reference

12 December 2020

The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.

1 reference

12 December 2020

Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients.

1 reference

12 December 2020

Antidepressants and Ejaculation: A Double-Blind, Randomized, Fixed-Dose Study With Mirtazapine and Paroxetine

1 reference

12 December 2020

Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold

1 reference

12 December 2020

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

1 reference

12 December 2020

A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.

1 reference

12 December 2020

Influence of mirtazapine on urinary free cortisol excretion in depressed patients

1 reference

12 December 2020

A multicentre, double-blind, amitriptyline-controlled study of mirtazapine in patients with major depression

1 reference

12 December 2020

A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report

1 reference

12 December 2020

10.2165/00023210-200923050-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1050067462

0 references

1 reference